{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:33:18Z","timestamp":1760297598175,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.metabol.2005.11.015","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T11:37:09Z","timestamp":1146137829000},"page":"599-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins"],"prefix":"10.1016","volume":"55","author":[{"given":"H. Christian","family":"Geiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus G.","family":"Parhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2005.11.015_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-2275(20)38178-5","article-title":"Identification of multiple subclasses of plasma low density lipoproteins in normal humans","volume":"23","author":"Krauss","year":"1982","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0021-9150(92)90255-F","article-title":"Variations in oxidative susceptibility among 6 low density lipoprotein subfractions of differing density and particle size","volume":"93","author":"Tribble","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2005.11.015_bib4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0022-2275(20)42342-9","article-title":"Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns","volume":"31","author":"La Belle","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0022-2275(20)41629-3","article-title":"Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor","volume":"32","author":"Nigon","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low-density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2005.11.015_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0026-0495(93)90199-X","article-title":"Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St Thomas' Atherosclerosis Regression Study (STARS)","volume":"42","author":"Watts","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.015_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.CIR.82.2.495","article-title":"Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk","volume":"82","author":"Austin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2005.11.015_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2005.11.015_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(94)90129-5","article-title":"Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk","volume":"106","author":"Griffin","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2005.11.015_bib11","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1161\/01.CIR.0000057982.50167.6E","article-title":"Relationships between LDL lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease","volume":"107","author":"Vakkilainen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2005.11.015_bib12","first-page":"1","article-title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men. 13-year follow-up data from the Quebec Cardiovascular Study","volume":"25","author":"St-Pierre","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2005.11.015_bib13","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.286.12.1468","article-title":"Low-density lipoprotein size, pravastatin treatment, and coronary events","volume":"286","author":"Campos","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2005.11.015_bib14","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1210\/jc.2003-030636","article-title":"Low density lipoprotein size and cardiovascular disease: a reappraisal","volume":"88","author":"Sacks","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"10.1016\/j.metabol.2005.11.015_bib15","first-page":"A24","article-title":"Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches","volume":"19","author":"Chapman","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2005.11.015_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4414\/smw.2004.10813","article-title":"LDL size: does it matter?","volume":"134","author":"Berneis","year":"2004","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.metabol.2005.11.015_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/eurheartj\/ehi231","article-title":"Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia","volume":"26","author":"Farnier","year":"2005","journal-title":"Eur J Heart"},{"key":"10.1016\/j.metabol.2005.11.015_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(02)03236-8","article-title":"Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia","volume":"91","author":"Kerzner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2005.11.015_bib19","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2005.11.015_bib20","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0735-1097(02)02610-4","article-title":"Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia","volume":"40","author":"Davidson","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2005.11.015_bib21","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.CIR.0000018744.58460.62","article-title":"Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia","volume":"105","author":"Gagne","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2005.11.015_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0002-9149(02)02774-1","article-title":"Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia","volume":"90","author":"Gagne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2005.11.015_bib23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4065\/79.5.620","article-title":"Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial","volume":"79","author":"Goldberg","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.metabol.2005.11.015_bib24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0195-668X(02)00803-5","article-title":"Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"24","author":"Melani","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2005.11.015_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0002-9149(02)02798-4","article-title":"Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia","volume":"90","author":"Dujovne","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2005.11.015_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4065\/80.5.587","article-title":"A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial","volume":"80","author":"Pearson","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.metabol.2005.11.015_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2004.11.007","article-title":"Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins","volume":"180","author":"Geiss","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2005.11.015_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1194\/jlr.M300523-JLR200","article-title":"In vivo metabolism of LDL subfractions in patients with heterozygous familial hypercholesterolemia on statin therapy: rebound analysis of LDL subfractions after LDL apheresis","volume":"45","author":"Geiss","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0022-2275(20)32381-6","article-title":"Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia","volume":"41","author":"Schamberger","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2005.11.015_bib30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.12.11.1284","article-title":"Change in LDL particle size is associated with change in plasma triglyceride concentration","volume":"12","author":"Mc Namara","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.metabol.2005.11.015_bib31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/meta.2001.24879","article-title":"Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects","volume":"50","author":"Geiss","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.015_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2002-32150","article-title":"Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia","volume":"110","author":"Geiss","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2005.11.015_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(96)06034-0","article-title":"Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia","volume":"129","author":"Homma","year":"1997","journal-title":"Atherosclerosis"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505004488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505004488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:11:36Z","timestamp":1758424296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049505004488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0026049505004488"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2005.11.015","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2005.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}